PD-1 Inhibitors Could Improve the Efficacy of Chemotherapy as First-Line Treatment in Biliary Tract Cancers: A Propensity Score Matching Based Analysis

BACKGROUND: There are limited treatment options for advanced biliary tract cancers (BTCs), including intrahepatic cholangiocarcinoma, extrahepatic bile duct cancer, gallbladder cancer. We compared the efficacy and safety of PD-1 inhibitors plus chemotherapy and chemotherapy alone as first-line treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Gou, Miaomiao, Zhang, Yong, Liu, Tiee, Si, Haiyan, Wang, Zhikuan, Yan, Huan, Qian, Niansong, Dai, Guanghai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248534/
https://www.ncbi.nlm.nih.gov/pubmed/34221968
http://dx.doi.org/10.3389/fonc.2021.648068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248534/
https://www.ncbi.nlm.nih.gov/pubmed/34221968
http://dx.doi.org/10.3389/fonc.2021.648068

Ejemplares similares